vs

Side-by-side financial comparison of Dorman Products, Inc. (DORM) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.

Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $537.9M, roughly 1.1× Dorman Products, Inc.). Hims & Hers Health, Inc. runs the higher net margin — 3.3% vs 2.1%, a 1.2% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs 0.8%). Dorman Products, Inc. produced more free cash flow last quarter ($33.5M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 7.1%).

Dorman Products is an American manufacturer of aftermarket automotive products in the United States. The company was founded in 1918. The company trades on the NASDAQ under the ticker DORM. The company is headquartered in Colmar, Pennsylvania.

Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.

DORM vs HIMS — Head-to-Head

Bigger by revenue
HIMS
HIMS
1.1× larger
HIMS
$617.8M
$537.9M
DORM
Growing faster (revenue YoY)
HIMS
HIMS
+27.6% gap
HIMS
28.4%
0.8%
DORM
Higher net margin
HIMS
HIMS
1.2% more per $
HIMS
3.3%
2.1%
DORM
More free cash flow
DORM
DORM
$36.0M more FCF
DORM
$33.5M
$-2.5M
HIMS
Faster 2-yr revenue CAGR
HIMS
HIMS
Annualised
HIMS
49.0%
7.1%
DORM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DORM
DORM
HIMS
HIMS
Revenue
$537.9M
$617.8M
Net Profit
$11.6M
$20.6M
Gross Margin
42.6%
71.9%
Operating Margin
5.8%
1.5%
Net Margin
2.1%
3.3%
Revenue YoY
0.8%
28.4%
Net Profit YoY
-78.8%
-20.8%
EPS (diluted)
$0.38
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DORM
DORM
HIMS
HIMS
Q4 25
$537.9M
$617.8M
Q3 25
$543.7M
$599.0M
Q2 25
$541.0M
$544.8M
Q1 25
$507.7M
$586.0M
Q4 24
$533.8M
$481.1M
Q3 24
$503.8M
$401.6M
Q2 24
$503.0M
$315.6M
Q1 24
$468.7M
$278.2M
Net Profit
DORM
DORM
HIMS
HIMS
Q4 25
$11.6M
$20.6M
Q3 25
$76.4M
$15.8M
Q2 25
$58.7M
$42.5M
Q1 25
$57.5M
$49.5M
Q4 24
$54.5M
$26.0M
Q3 24
$55.3M
$75.6M
Q2 24
$47.4M
$13.3M
Q1 24
$32.8M
$11.1M
Gross Margin
DORM
DORM
HIMS
HIMS
Q4 25
42.6%
71.9%
Q3 25
44.4%
73.8%
Q2 25
40.6%
76.4%
Q1 25
40.9%
73.5%
Q4 24
41.5%
76.8%
Q3 24
40.5%
79.2%
Q2 24
39.6%
81.3%
Q1 24
38.7%
82.4%
Operating Margin
DORM
DORM
HIMS
HIMS
Q4 25
5.8%
1.5%
Q3 25
19.4%
2.0%
Q2 25
15.2%
4.9%
Q1 25
15.8%
9.9%
Q4 24
16.3%
3.9%
Q3 24
15.7%
5.6%
Q2 24
14.4%
3.5%
Q1 24
11.6%
3.6%
Net Margin
DORM
DORM
HIMS
HIMS
Q4 25
2.1%
3.3%
Q3 25
14.1%
2.6%
Q2 25
10.9%
7.8%
Q1 25
11.3%
8.4%
Q4 24
10.2%
5.4%
Q3 24
11.0%
18.8%
Q2 24
9.4%
4.2%
Q1 24
7.0%
4.0%
EPS (diluted)
DORM
DORM
HIMS
HIMS
Q4 25
$0.38
$0.08
Q3 25
$2.48
$0.06
Q2 25
$1.91
$0.17
Q1 25
$1.87
$0.20
Q4 24
$1.76
$0.10
Q3 24
$1.80
$0.32
Q2 24
$1.53
$0.06
Q1 24
$1.05
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DORM
DORM
HIMS
HIMS
Cash + ST InvestmentsLiquidity on hand
$49.4M
$228.6M
Total DebtLower is stronger
$440.6M
Stockholders' EquityBook value
$1.5B
$540.9M
Total Assets
$2.5B
$2.2B
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DORM
DORM
HIMS
HIMS
Q4 25
$49.4M
$228.6M
Q3 25
$55.5M
$345.8M
Q2 25
$56.8M
$1.1B
Q1 25
$60.6M
$273.7M
Q4 24
$57.1M
$220.6M
Q3 24
$45.1M
$165.5M
Q2 24
$47.5M
$129.3M
Q1 24
$34.4M
$105.2M
Total Debt
DORM
DORM
HIMS
HIMS
Q4 25
$440.6M
Q3 25
Q2 25
Q1 25
Q4 24
$468.8M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DORM
DORM
HIMS
HIMS
Q4 25
$1.5B
$540.9M
Q3 25
$1.5B
$581.0M
Q2 25
$1.4B
$562.7M
Q1 25
$1.3B
$549.3M
Q4 24
$1.3B
$476.7M
Q3 24
$1.2B
$440.1M
Q2 24
$1.2B
$362.0M
Q1 24
$1.2B
$344.5M
Total Assets
DORM
DORM
HIMS
HIMS
Q4 25
$2.5B
$2.2B
Q3 25
$2.6B
$2.2B
Q2 25
$2.5B
$1.9B
Q1 25
$2.4B
$891.7M
Q4 24
$2.4B
$707.5M
Q3 24
$2.4B
$602.3M
Q2 24
$2.3B
$480.5M
Q1 24
$2.2B
$448.1M
Debt / Equity
DORM
DORM
HIMS
HIMS
Q4 25
0.30×
Q3 25
Q2 25
Q1 25
Q4 24
0.36×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DORM
DORM
HIMS
HIMS
Operating Cash FlowLast quarter
$41.6M
$61.3M
Free Cash FlowOCF − Capex
$33.5M
$-2.5M
FCF MarginFCF / Revenue
6.2%
-0.4%
Capex IntensityCapex / Revenue
1.5%
10.3%
Cash ConversionOCF / Net Profit
3.60×
2.98×
TTM Free Cash FlowTrailing 4 quarters
$75.7M
$57.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DORM
DORM
HIMS
HIMS
Q4 25
$41.6M
$61.3M
Q3 25
$12.2M
$148.7M
Q2 25
$8.5M
$-19.1M
Q1 25
$51.2M
$109.1M
Q4 24
$71.4M
$86.4M
Q3 24
$44.3M
$85.3M
Q2 24
$63.3M
$53.6M
Q1 24
$52.0M
$25.8M
Free Cash Flow
DORM
DORM
HIMS
HIMS
Q4 25
$33.5M
$-2.5M
Q3 25
$1.8M
$79.3M
Q2 25
$98.0K
$-69.5M
Q1 25
$40.3M
$50.1M
Q4 24
$63.2M
$59.5M
Q3 24
$35.7M
$79.4M
Q2 24
$51.4M
$47.6M
Q1 24
$41.2M
$11.8M
FCF Margin
DORM
DORM
HIMS
HIMS
Q4 25
6.2%
-0.4%
Q3 25
0.3%
13.2%
Q2 25
0.0%
-12.8%
Q1 25
7.9%
8.5%
Q4 24
11.8%
12.4%
Q3 24
7.1%
19.8%
Q2 24
10.2%
15.1%
Q1 24
8.8%
4.3%
Capex Intensity
DORM
DORM
HIMS
HIMS
Q4 25
1.5%
10.3%
Q3 25
1.9%
11.6%
Q2 25
1.6%
9.3%
Q1 25
2.2%
10.1%
Q4 24
1.5%
5.6%
Q3 24
1.7%
1.5%
Q2 24
2.4%
1.9%
Q1 24
2.3%
5.0%
Cash Conversion
DORM
DORM
HIMS
HIMS
Q4 25
3.60×
2.98×
Q3 25
0.16×
9.43×
Q2 25
0.15×
-0.45×
Q1 25
0.89×
2.20×
Q4 24
1.31×
3.32×
Q3 24
0.80×
1.13×
Q2 24
1.34×
4.03×
Q1 24
1.58×
2.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DORM
DORM

Light Duty$428.6M80%
Heavy Duty$55.8M10%
Specialty Vehicle$53.5M10%

HIMS
HIMS

Segment breakdown not available.

Related Comparisons